MMI Timeline

Events

• 2026-10-08 - Funding - MMI raises $125 million Series D for Symani commercial expansion - Approximately 50 Symani systems are installed, with 3,500 complex microsurgical procedures performed worldwide. Proceeds support expansion in the United States and other markets, clinical evidence including REMIND, and energy-instrument and digital-surgery… - source: globenewswire.com
• 2026-09-16 - Funding - MMI receives €17M EIB–Angelini Ventures co-investment - The financing is the third completed investment under the investors’ €150M European life-sciences programme. MMI manufactures the Symani system in Pisa for microsurgery and super-microsurgery. EIB and Angelini Ventures each committed €75M to the six-year… - source: angeliniventures.com
• 2026-07-30 - Regulatory - MMI receives FDA approval to expand REMIND microsurgery study - The supplement followed FDA review of 30-day safety data from the first patient cohort. REMIND evaluates Symani-enabled microsurgical techniques intended to re-establish deep-cervical lymphatic drainage in patients with Alzheimer's disease and confirmed… - source: globenewswire.com
• 2024-02-21 - Funding - MMI completes Series C financing led by Fidelity - All existing investors participated in the financing. The capital was allocated to high-growth-market commercialization, indication-expansion studies, advanced technology and global operations. The round extended the company’s funding base for microsurgery… - source: mmimicro.com
• 2022-07-20 - Funding - MMI completes Series B financing for Symani commercialization - RA Capital Management and BioStar Capital joined the round alongside Andera Partners, Fountain Healthcare Partners, Panakès Partners and Sambatech. The financing supported European commercialization, U.S. and Asia-Pacific market plans, and clinical research.… - source: mmimicro.com